National surgical wait times strategy needed
The long waits lead to more pain and suffering, further deterioration of joints, more challenging surgeries, and increased costs to the health system and economy.
Time for Poilievre to join a constructive pharmacare conversation
Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre Poilievre’s turn.
House Health Committee calls for a national breast implant registry
Canada is the only G7 country without a national breast implant registry. March 29 marked the 120-day deadline for the government to respond to the House Health Committee’s recommendations for such a registry.
School food program should focus on healthy plant-based eating
The National School Food Program announcement is reason to celebrate, especially if it can help the shift to more plant-based consumption. Not only are there are big environmental, economic and health benefits from this shift, but it’s a reminder that the health and well-being of humans, animals, and the planet are interconnected.
Pharmacare bill offers too much ambiguity and too little ambition
To understand and maximize value, we should know why the government chose this odd-duck model, and diabetes and contraception drugs over others. Politics over public health, perhaps?
Dental hygienists have powerful potential to improve oral health care delivery in Canada
Ottawa can better support the oral health care of long-term care residents by implementing national standards and team-based care that includes dental hygienists.
Profit is not the cure
Canada’s health-care crisis cannot be solved by opening the door to corporate greed.
Equity must be the priority for national pharmacare
Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
Pharmacare pivotal to ensure vital medications for all Canadians: CML Society of Canada
Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the Pharmacare Act as a pivotal measure to ensure universal access to vital medications for all Canadians. Its multi-faceted approach—including collaboration, policy development, and strategic initiatives such as national pharmacare and bulk […]
A national pharmacare plan should cover what’s best for patients, not what’s new
Using insulin is always challenging, so access to a broad range of appropriate options is vital.
